Patient ka birth weight 3kg tha
Ssc tak normal growth and weight
Last 15-20 years se increase in weight and more since last 10 years
No cardiac family history nil addiction no psychiatric illness
Waist height ratio is 1.03
Hypertension dm insulin resistance not present total cholesterol 78 hdl 5 triglyceride -125
Central obesity > peripheral
The note suggests severe class III obesity with very high central adiposity, plus edema, reported hepatosplenomegaly, and possible sleep-breathing symptoms. These need clinician-led assessment rather than being attributed only to lifestyle. The HDL value of 5 and total cholesterol of 78 should also be repeated with units and a full fasting lipid panel confirmed.
Asking for Preferences
What would you like me to prepare from this case?
The note suggests severe class III obesity with very high central adiposity, plus edema, reported hepatosplenomegaly, and possible sleep-breathing symptoms. These need clinician-led assessment rather than being attributed only to lifestyle. The HDL value of 5 and total cholesterol of 78 should also be repeated with units and a full fasting lipid panel confirmed.
This is extreme class III obesity / super-super obesity with marked central adiposity:
Height: about 174 cm
Waist: about 180 cm, giving waist-to-height ratio 1.03. A ratio above 0.5 indicates increased cardiometabolic risk.
The handwritten note appears to record BMI around 103 kg/m², but the exact current weight should be reconfirmed.
Gradual weight gain began in adult life, more pronounced over the past 10 years.
No diabetes, hypertension, or documented insulin resistance at present.
Likely physical complications already present: bilateral edema, osteoarthritis or mobility limitation, and possible respiratory/sleep-related complication.
STOP-BANG score 6/8 and neck circumference around 62 cm indicate a very high probability of obstructive sleep apnea.
Priority concerns
Obstructive sleep apnea and obesity hypoventilation syndrome
With severe obesity, high STOP-BANG, large neck circumference, edema, and any breathlessness or daytime somnolence, assess urgently for OSA and OHS.
OHS is obesity plus awake carbon-dioxide retention and sleep-disordered breathing. It can lead to pulmonary hypertension, right-heart failure, and worsening edema.
Obtain resting SpO₂, serum bicarbonate, ABG or arterialised capillary blood gas if bicarbonate is raised or clinical suspicion is high, and arrange sleep study or respiratory polygraphy. The NICE OHS guidance recommends awake blood-gas testing when OHS is suspected and notes that bicarbonate below 27 mmol/L makes OHS less likely in low-probability settings.
Hepatomegaly plus splenomegaly
The note appears to state hepatomegaly 18 cm and splenomegaly 16 cm.
Simple obesity can cause MASLD, previously called fatty liver disease, but splenomegaly is not something to dismiss as uncomplicated obesity. It needs evaluation for advanced liver disease/portal hypertension, congestive hepatopathy from right-sided cardiac strain, hematologic disease, and infection depending on symptoms.
Do abdominal ultrasound with Doppler, liver stiffness assessment if available, CBC with peripheral smear, LFTs, albumin, PT/INR, bilirubin, viral hepatitis tests, and renal profile.
Edema
Clarify pitting vs non-pitting, onset, symmetry, dyspnea, orthopnea, reduced urine output, and medication history.
Evaluate cardiac, renal, hepatic, venous/lymphatic causes, and OHS-related pulmonary hypertension.
ECG, echocardiography, urine protein/albumin-creatinine ratio, creatinine/eGFR, serum albumin, LFTs, and chest assessment are appropriate.
Very low HDL reported as 5 mg/dL
This requires repeat fasting lipid profile with LDL-C, non-HDL-C, ApoB, and preferably direct HDL measurement.
If HDL truly is 5 mg/dL with triglycerides only 125 mg/dL, consider laboratory error first, then secondary causes or rare inherited severe HDL disorders. Isolated low HDL with otherwise normal triglycerides can warrant consideration of primary genetic or specific secondary causes.
Confirm the units and whether HDL may have been recorded as 35 rather than 5.
Thyroid results
TSH 0.35 with low FT3 is not a typical pattern for primary hypothyroidism causing obesity.
Repeat TSH, FT4, FT3 when clinically stable. Interpret with medication history and systemic illness; do not start thyroid hormone solely to treat obesity without confirming a thyroid disorder.
Working problem list
Extreme central obesity, likely severe adiposity-based chronic disease
High risk OSA, rule out OHS
Peripheral edema, evaluate for right-heart strain/pulmonary hypertension, renal, hepatic, venous, and lymphatic causes
Hepatomegaly with splenomegaly, rule out advanced MASLD/portal hypertension and hematologic causes
Severe mobility impairment and osteoarthritis
Extremely low HDL value needing verification
Need to exclude secondary contributors to weight gain, especially medications, Cushing syndrome only if clinical features are present, hypogonadism/PCOS where relevant, and sleep-related worsening of weight and function
ABG/capillary gas plus serum bicarbonate, sleep study
USG abdomen with portal/hepatic Doppler, liver stiffness assessment where available
Management direction
This patient needs multidisciplinary obesity treatment, not lifestyle advice alone:
Respiratory/sleep specialist review urgently if somnolence, low SpO₂, morning headache, breathlessness, or edema are present.
Dietitian-led, high-protein calorie-deficit plan adapted to mobility and financial constraints.
Physiotherapy focused on bed-based or chair-based activity initially, then progressive ambulation.
Treat OSA/OHS with CPAP or NIV if confirmed, before considering surgery.
Evaluate anti-obesity pharmacotherapy after contraindications and affordability are reviewed.
Given the apparent BMI near 100 kg/m² and substantial functional/respiratory burden, refer early to a high-volume bariatric/metabolic surgery center. Surgery assessment requires optimization of respiratory, cardiac, hepatic, nutritional, mobility, and psychological risks first.
Urgent referral or emergency assessment now if
Resting SpO₂ low, cyanosis, confusion, excessive sleepiness, or morning headaches
Fever/red painful swollen leg, leg ulceration, or suspected cellulitis
Abdominal pain, jaundice, GI bleeding, or rapidly increasing abdominal distension
The key point is that the absence of diabetes and hypertension is favorable, but it does not mean risk is low. Respiratory failure risk, sleep apnea, edema, functional disability, liver disease, and possible cardiopulmonary complications need priority assessment.
Make a bariatric surgery preoperative assessment plan
Provisional risk category: Very high risk because of probable extreme obesity, central adiposity, limited mobility, edema, very high OSA risk, and reported hepatomegaly with splenomegaly. Surgery should be planned only in a high-volume tertiary bariatric center with bariatric anesthesia, respiratory medicine, cardiology, hepatology, and ICU/HDU backup.
Current clearance status: Not fit for elective bariatric surgery until respiratory, cardiac, edema, and liver-spleen evaluation is completed and optimized.
1. Confirm baseline anthropometry and surgical eligibility
Assessment
Action
Weight and BMI
Measure calibrated standing weight or bariatric-bed scale; confirm height and calculate BMI. The handwritten BMI/weight values appear inconsistent and must be verified.
Central adiposity
Record waist circumference and waist-to-height ratio. Current ratio 1.03 indicates marked central adiposity.
Functional status
Document ability to stand/walk, stairs, METs if measurable, falls risk, need for mobility aid, ADL dependence, and baseline exercise tolerance.
Weight history
Record highest adult weight, trajectory, previous supervised diets, medications, anti-obesity drug use, previous attempts at weight loss, and causes of weight gain.
Procedure planning
Do not select sleeve, gastric bypass, or a staged procedure until reflux, liver status, anesthesia risk, eating behavior, and nutritional assessment are complete.
2. Multidisciplinary bariatric team assessment
Mandatory team members:
Bariatric surgeon
Bariatric anesthetist
Physician/endocrinologist or obesity-medicine specialist
Dietitian experienced in bariatric nutrition
Clinical psychologist/psychiatrist
Respiratory physician or sleep specialist
Physiotherapist and rehabilitation team
Cardiologist if abnormal symptoms, ECG/echo, edema, or poor functional capacity
Hepatologist/gastroenterologist because of hepatomegaly and splenomegaly
Social worker/case coordinator if finances, caregiver support, transport, equipment, or long-term follow-up are barriers
Bariatric preoperative evaluation should include optimization of medical, nutritional, and psychological comorbidity, with specific screening for coronary disease, pulmonary disease, OSA/OHS, and diabetes. This is consistent with Schwartz’s Principles of Surgery preoperative bariatric assessment framework.
3. Respiratory and sleep assessment: highest immediate priority
STOP-BANG score. Current score reportedly 6/8, which indicates high OSA probability.
Neck circumference, current note approximately 62 cm
Smoking/vaping history, asthma/COPD, previous ventilation or ICU admission
Investigations
Sleep study or respiratory polygraphy before surgery.
Serum bicarbonate.
Awake ABG or arterialised capillary blood gas if bicarbonate is elevated, resting hypoxemia exists, daytime somnolence/morning headache is present, or clinical probability of OHS is high.
Chest X-ray if symptoms/signs warrant it.
Spirometry/PFTs if respiratory symptoms, suspected COPD/restrictive disease, or anesthesia team requests it.
Optimization required before surgery
Initiate and document adherence to CPAP for OSA or NIV/BiPAP for OHS if confirmed.
Bring personal CPAP/NIV device to hospital.
Do not proceed electively with untreated suspected OHS, resting hypoxemia, or unexplained hypercapnia.
Plan post-op monitored bed, likely HDU/ICU-level observation depending on gas exchange and OSA/OHS severity.
The NICE OHS guidance recommends awake blood-gas testing when OHS is suspected; it notes that serum bicarbonate below 27 mmol/L makes OHS unlikely in low pre-test probability cases.
4. Cardiac, edema, and peri-anesthetic assessment
Key concern
The presence of edema with very severe obesity and high OSA/OHS risk raises concern for:
Pulmonary hypertension
Right ventricular dysfunction/cor pulmonale
Heart failure with preserved ejection fraction
Venous insufficiency or lymphedema
Renal disease
Liver disease with hypoalbuminemia or portal hypertension
5. Hepatomegaly and splenomegaly: complete before clearance
Reported 18 cm hepatomegaly and 16 cm splenomegaly require confirmation. Do not label this as simple fatty liver until evaluated.
Tests
CBC with platelet count and peripheral smear
LFT: AST, ALT, ALP, GGT, bilirubin
Serum albumin and total protein
PT/INR
Creatinine/eGFR and electrolytes
Hepatitis B surface antigen and hepatitis C antibody, with further viral testing as indicated
Ferritin and transferrin saturation
Abdominal ultrasound with liver, spleen, portal vein, hepatic veins, and Doppler
Liver stiffness measurement/FibroScan if feasible
Hepatology review if splenomegaly, thrombocytopenia, abnormal synthetic function, portal-vein abnormality, advanced fibrosis, or cirrhosis is suspected
Surgical implication
Significant portal hypertension, decompensated cirrhosis, major coagulopathy, or unexplained splenomegaly requires specialist decision-making and may defer or change the surgical approach.
6. Metabolic and endocrine work-up
Core laboratory panel
Fasting plasma glucose and HbA1c
Fasting lipid profile: total cholesterol, LDL-C, HDL-C, triglycerides, non-HDL-C
ApoB if available
CBC
Renal function, electrolytes, liver panel, albumin
Urine routine and urine albumin-creatinine ratio
TSH and free T4. Repeat FT3 only if endocrinology considers it clinically useful.
HDL issue
The reported HDL 5 mg/dL and total cholesterol 78 mg/dL need urgent verification:
Repeat fasting lipid profile at a reliable lab
Check units and transcription accuracy
If HDL remains extremely low with normal triglycerides, assess for secondary causes and consider lipid specialist input for rare genetic hypoalphalipoproteinemia
Screen for secondary obesity only if clinically indicated
Medication-induced weight gain: steroids, antipsychotics, antidepressants, antiepileptics, insulin/sulfonylureas, etc.
Cushing syndrome testing only if there are suggestive features such as proximal muscle weakness, easy bruising, wide violaceous striae, facial plethora, unexplained osteoporosis, or early/severe hypertension/diabetes
PCOS assessment if relevant: menstrual irregularity, acne, hirsutism, infertility
Binge eating, grazing, night eating, emotional eating
Protein intake and hydration
Food insecurity, affordability, cultural eating pattern
Understanding of lifelong diet stages, supplementation, follow-up, and alcohol risks after surgery
Baseline nutritional tests
CBC, ferritin, iron, TIBC/transferrin saturation
Vitamin B12 and folate
25-OH vitamin D, calcium, phosphate, PTH
Thiamine if vomiting, poor intake, or high nutritional risk
Albumin
Consider vitamin A, zinc, copper, and selenium based on planned procedure, nutritional risk, or local protocol
Optimization
Correct iron, B12, folate, vitamin D/calcium, thiamine, and protein deficiencies before surgery.
Start the bariatric program’s prescribed multivitamin/mineral regimen.
Begin a supervised preoperative liver-reduction diet, usually a short low-calorie or very-low-calorie protocol, individualized by the bariatric team.
A 2025 systematic review found that VLCD-based preoperative programs may reduce perioperative complications, although certainty of evidence was low (systematic review).
8. Psychological and behavioral assessment
Assessment must not be a formality. It should address:
Capacity for informed consent
Understanding that surgery is a tool, not a cure
Expectations for weight loss, body image, mobility, and social changes
Active alcohol, tobacco, opioid, or other substance use
Current psychiatric treatment and stability
Caregiver support, adherence history, financial capacity for lifelong supplements and follow-up
Potential reasons to defer surgery: uncontrolled psychiatric illness, active substance-use disorder, untreated binge-purge behavior, inability to adhere to postoperative requirements, or absence of a safe follow-up plan.
9. Gastrointestinal and procedure-specific assessment
Ask specifically about GERD, dysphagia, vomiting, peptic ulcer disease, NSAID use, prior abdominal surgery, gallstone symptoms, and GI bleeding.
Upper GI endoscopy if reflux, dysphagia, anemia, persistent upper-GI symptoms, NSAID use, suspected ulcer disease, planned revisional surgery, or as required by local bariatric protocol.
Test/treat H. pylori according to local program policy.
Gallbladder ultrasound if biliary symptoms or local preoperative protocol indicates.
If significant reflux/Barrett’s esophagus is present, procedure selection needs surgeon and GI input because sleeve gastrectomy may worsen reflux in some patients.
10. Venous thromboembolism plan
This patient is likely at very high VTE risk because of extreme obesity, reduced mobility, and possible cardiopulmonary disease.
Preoperative VTE checklist
Previous DVT/PE
Family thrombosis history
Known thrombophilia
Chronic venous insufficiency, leg ulcer, immobility
Create a written stop/continue plan for the day before and day of surgery. In particular, GLP-1 medication timing should follow the local anesthesia protocol and be individualized based on dose escalation, GI symptoms, aspiration risk, and glycemic status.
12. Prehabilitation and logistics
Start before surgery:
Respiratory physiotherapy and incentive spirometry teaching
Chair-based or bed-based exercise progressing to supervised walking as tolerated
Resistance training where feasible to preserve muscle mass
Skin-fold care, pressure injury prevention, and treatment of fungal intertrigo/cellulitis
Edema management after cardiac/renal/hepatic causes are assessed
Smoking cessation, if applicable, with nicotine testing per program policy
Confirm home support, transport, bariatric equipment, CPAP/NIV access, and ability to attend frequent follow-ups
Discuss staged surgery if technical/anesthetic risk is excessive
Clearance checklist before proceeding
Proceed to elective bariatric surgery only when all applicable items are complete:
Accurate weight, height, BMI, waist, functional assessment documented
Bariatric surgeon, anesthetist, dietitian, psychologist, and physician assessment completed
Sleep study completed and OSA/OHS treated or perioperative plan documented
ABG/capillary blood gas reviewed if OHS suspected
Echocardiogram and cardiology review completed if edema, low functional capacity, abnormal ECG, or cardiopulmonary symptoms
Edema cause assessed and optimized
Hepatosplenomegaly evaluated with imaging, CBC/platelets, liver synthetic function, and hepatology input where needed
Nutritional deficiencies corrected or active replacement started